Geode Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-1,800,929
Closed -$160M – 4151
2017
Q1
$160M Buy
1,800,929
+154,638
+9% +$12.7M 0.07% 298
2016
Q4
$116M Buy
1,646,291
+89,675
+6% +$6.68M 0.05% 344
2016
Q3
$123M Buy
1,556,616
+36,013
+2% +$3.07M 0.06% 313
2016
Q2
$138M Sell
1,520,603
-59,829
-4% -$5.07M 0.07% 271
2016
Q1
$134M Buy
1,580,432
+7,865
+0.5% +$585K 0.07% 263
2015
Q4
$124M Sell
1,572,567
-74,020
-4% -$5.83M 0.07% 277
2015
Q3
$116M Buy
1,646,587
+37,460
+2% +$3.08M 0.07% 285
2015
Q2
$145M Buy
1,609,127
+18,415
+1% +$1.78M 0.08% 247
2015
Q1
$160M Buy
1,590,712
+65,733
+4% +$6.63M 0.09% 230
2014
Q4
$153M Buy
1,524,979
+74,463
+5% +$7.42M 0.09% 234
2014
Q3
$139M Sell
1,450,516
-13,979
-1% -$1.32M 0.09% 224
2014
Q2
$136M Sell
1,464,495
-2,248
-0.2% -$197K 0.09% 231
2014
Q1
$122M Sell
1,466,743
-3,421
-0.2% -$277K 0.08% 246
2013
Q4
$123M Buy
1,470,164
+71,308
+5% +$5.81M 0.09% 232
2013
Q3
$104M Buy
1,398,856
+44,895
+3% +$3.37M 0.08% 256
2013
Q2
$107M Buy
+1,353,961
New +$109M 0.09% 221

Other funds holding MJN

Geode Capital Management's MJN Position: Q2 2017 in Review

Geode Capital Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 1,800,929 shares — an estimated $160M sold.

Geode Capital Management first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $160M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Geode Capital Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Geode Capital Management sold 1,800,929 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $160M.
  • Geode Capital Management first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Geode Capital Management's Mead Johnson Nutrition Company position peaked at $160M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.